The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q4 2022 call → NOWe need answer YES/NO based on transcript. Need determine if management describes growing share of revenue arriving without new selling event through reorders/refills/renewals etc, and that this self-arriving share has recently and visibly grown as proportion, grounded in observed current behavior. We need parse transcript. Company Regeneron. Products: EYLEA, Dupixent, Libtayo, etc. Are these recurring? Dupixent is chronic disease biologic, patients refill prescriptions. But does management describe growing share of revenue from repeat/refill? They discuss growth in sales, market share, patient starts. But not specifically "self-arriving revenue" proportion. They talk about Dupixent growth across indications, launches. EYLEA injections are repeat treatments but not described as reorders. Libtayo etc. No mention of recurring revenue model. The question asks about "self-arriving revenue" through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket, consumable pull-through. In pharma, chronic meds have refills, but management doesn't frame it as such. They discuss "new patient starts" and "total prescriptions" for Dupixent. But no explicit statement that share of revenue from repeat is growing. They mention "steady growth in total prescriptions and new patient starts" but not proportion. Also "customer ordering has accelerated" for Libtayo after approval. Not about repeat. Need answer NO. Because no such description. The transcript is about pipeline, launches, sales growth. No mention of recurring revenue shift. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.